Skip to main content

Table 2 Univariate analysis comparing good-adherent to poor-adherent patients, Lifou, New Caledonia, 2011

From: Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study

Characteristics

Good-adherent patientsn/N (%)

Poor-adherent patientsn/N (%)

P value*

Demographic and socio-economic characteristics

   

Age <16 years old

  

0.092

 No

18/38 (47)

22/32 (69)

 

 Yes

20/38 (53)

10/32 (31)

 

Male sex

  

0.215

 No

21/38 (55)

23/32 (72)

 

 Yes

17/38 (45)

9/32 (28)

 

Concrete dwelling

  

0.466

 No

25/38 (66)

18/32 (56)

 

 Yes

13/38 (34)

14/32 (44)

 

Number of persons in the household ≥ 6

  

0.054

 No

13/38 (24)

19/32 (59)

 

 Yes

25/38 (66)

13/32 (41)

 

Other case(s) of ARF in the household

  

0.320

 No

30/37 (81)

29/32 (91)

 

 Yes

7/37 (19)

3/32 (9)

 

Household income <150 000 CFP (1,600 USD)/month

  

1

 No

14/38 (37)

10/29 (34)

 

 Yes

24/38 (63)

19/29 (66)

 

Health care team and system-related characteristics

  

Follow up of ARF/RHD in a health center

  

1

 No

3/38 (8)

2/32 (6)

 

 Yes

35/38 (92)

30/32 (94)

 

Follow up of ARF/RHD in the health center of Xépénéhé

  

0.140

 No

13/35 (37)

17/30 (57)

 

 Yes

22/35 (63)

13/30 (43)

 

Distance between the residence and the nearest health center >5 km

  

0.116

 No

14/38 (37)

6/32 (19)

 

 Yes

24/37 (63)

26/32 (81)

 

Duration for an injection >3 h §

  

0.257

 No

23/29 (79)

24/26 (92)

 

 Yes

6/29 (21)

2/26 (8)

 

BPG injections’ recall system

  

0.042

 No

37/37 (100)

28/32 (88)

 

 Yes

0/37 (0)

4/32 (12)

 

Adequate healthcare coverage

  

0.070

 No

8/37 (22)

14/32 (44)

 

 Yes

29/37 (78)

18/32 (56)

 

Condition-related characteristics

   

Previous history of ARF

  

0.121

 No

10/38 (26)

3/32 (9)

 

 Yes

28/38 (74)

29/32 (91)

 

Previous history of RHD

  

1

 No

9/38 (24)

7/32 (22)

 

 Yes

29/38 (76)

25/32 (78)

 

Severe RHD at diagnosis**

  

1

 No

25/29 (86)

19/22 (86)

 

 Yes

4/29 (14)

3/22 (14)

 

Hospitalization at diagnosis of ARF or RHD

  

0.813

 No

18/36 (50)

17/32 (53)

 

 Yes

18/36 (50)

15/32 (47)

 

Therapy-related characteristics

   

Treatment duration >2 years

  

0.743

 No

5/37 (14)

6/32 (19)

 

 Yes

32/37 (86)

26/32 (81)

 

Severe pain from BPG injection

  

0.130

 No

36/38 (95)

26/32 (81)

 

 Yes

2/38 (5)

6/32 (19)

 

Desire for oral treatment

  

1

 No

32/38 (84)

24/28 (86)

 

 Yes

6/38 (16)

4/28 (14)

 

Confidence in treatment

  

0.316

 No

1/36 (3)

3/29 (10)

 

 Yes

35/36 (97)

26/29 (90)

 

Patient-related characteristics

   

Protestant religion

  

0.602

 No

10/38 (26)

11/32 (34)

 

 Yes

28/38 (74)

21/32 (66)

 

Knowledge of treatment’s objectives

  

1

 No

2/32 (6)

2/27 (7)

 

 Yes

30/32 (94)

25/27 (93)

 
  1. CI denotes confidence interval, ARF denotes acute rheumatic fever and RHD denotes rheumatic heart disease.
  2. *P values were calculated with the use of Fisher’s exact test for categorical variables and Student’s test for continue variables.
  3. § The duration includes transport from home to health center, way and back. Patients having injections at home were excluded.
  4. ¶ Declarative information.
  5. ** The classification of severity was obtained by echocardiography medical records.